Distribution of Protein Content and Number of Aggregates in Monoclonal Antibody Formulation After Large-Scale Freezing

Cryoconcentration of an in-house IgG1 and number of aggregates in a formulation containing trehalose were determined in dependence on freezing protocol and volume. Morphology changes of ice crystals depending on cooling rates were captured by optical cryomicroscopy (OCM) images. UV-Vis and affinity chromatography (ALC) was used to determine protein content and size-exclusion chromatography (SEC) for detection of aggregates. Cooling to − 80°C rather than − 20°C is beneficial in avoiding hot spots of high protein concentration. An upscaling of 250 ml to 2 L bottles results in an up to fourfold increase of macroscopic cryoconcentration. There is no direct correlation between number of aggregates and macroscopic cryoconcentration. Aggregate formation of that specific mAb is not caused by macroscopic cryoconcentration but can be directly linked to microscopic cryoconcentration in between the ice dendrites. Slower cooling with set-point and storage temperatures below Tg’ has proven to be advantageous for the prevention of aggregate formation. We reveal that the subcooling prior to freezing plays a key role in avoiding aggregates. The lower the solution is supercooled the more likely aggregates form. As a consequence, we suggest controlled initiation of the freezing process to avoid large supercooling.

[1]  P. Temussi,et al.  Cold denaturation as a tool to measure protein stability , 2016, Biophysical chemistry.

[2]  Bernd Nidetzky,et al.  Design of experiments reveals critical parameters for pilot-scale freeze-and-thaw processing of L-lactic dehydrogenase. , 2015, Biotechnology journal.

[3]  S. Singh,et al.  Frozen-state storage stability of a monoclonal antibody: aggregation is impacted by freezing rate and solute distribution. , 2013, Journal of pharmaceutical sciences.

[4]  A. Heymsfield,et al.  Ice Crystals Growing from Vapor in Supercooled Clouds between −2.5° and −22°C: Testing Current Parameterization Methods Using Laboratory Data , 2011 .

[5]  R. Suryanarayanan,et al.  The Effect of Crystallizing and Non-crystallizing Cosolutes on Succinate Buffer Crystallization and the Consequent pH Shift in Frozen Solutions , 2011, Pharmaceutical Research.

[6]  Min Huang,et al.  Frozen State Storage Instability of a Monoclonal Antibody: Aggregation as a Consequence of Trehalose Crystallization and Protein Unfolding , 2011, Pharmaceutical Research.

[7]  W. Jiskoot,et al.  Structural properties of monoclonal antibody aggregates induced by freeze-thawing and thermal stress. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[8]  Hanns-Christian Mahler,et al.  Protein aggregation: pathways, induction factors and analysis. , 2009, Journal of pharmaceutical sciences.

[9]  Brian Kelley,et al.  Industrialization of mAb production technology: The bioprocessing industry at a crossroads , 2009, mAbs.

[10]  J. Carpenter,et al.  Effects of solution conditions, processing parameters, and container materials on aggregation of a monoclonal antibody during freeze-thawing. , 2008, Journal of pharmaceutical sciences.

[11]  Nitin Rathore,et al.  Current Perspectives on Stability of Protein Drug Products during Formulation, Fill and Finish Operations , 2008, Biotechnology progress.

[12]  A. Rosenberg,et al.  Effects of protein aggregates: An immunologic perspective , 2006, The AAPS Journal.

[13]  Huub Schellekens,et al.  Structure-Immunogenicity Relationships of Therapeutic Proteins , 2004, Pharmaceutical Research.

[14]  Enhong Cao,et al.  Effect of freezing and thawing rates on denaturation of proteins in aqueous solutions. , 2003, Biotechnology and bioengineering.

[15]  V. N. Kazakov,et al.  Dynamics of protein and mixed protein/surfactant adsorption layers at the water/fluid interface. , 2000, Advances in colloid and interface science.

[16]  M. Toner,et al.  Literature review: supplemented phase diagram of the trehalose-water binary mixture. , 2000, Cryobiology.

[17]  M. Malmsten,et al.  Spray-drying of trypsin - surface characterisation and activity preservation. , 1999, International journal of pharmaceutics.

[18]  B. Chang,et al.  Surface-induced denaturation of proteins during freezing and its inhibition by surfactants. , 1996, Journal of pharmaceutical sciences.

[19]  E. Gabellieri,et al.  Proteins in frozen solutions: evidence of ice-induced partial unfolding. , 1996, Biophysical journal.

[20]  J. Klett,et al.  Microphysics of Clouds and Precipitation , 1978, Nature.

[21]  H. Pruppacher On the growth of ice crystals in supercooled water and aqueous solution drops , 1967 .

[22]  N. Coggeshall,et al.  Concentration of Impurities from Organic Compounds by Progressive Freezing , 1959 .

[23]  L. van den Berg,et al.  Effect of freezing on the pH and composition of sodium and potassium phosphate solutions; the reciprocal system KH2PO4-Na2-HPO4-H2O. , 1959, Archives of biochemistry and biophysics.

[24]  Chung C. Hsu,et al.  Surface Denaturation at Solid-Void Interface—A Possible Pathway by Which Opalescent Participates Form During the Storage of Lyophilized Tissue-Type Plasminogen Activator at High Temperatures , 2004, Pharmaceutical Research.

[25]  S. D. Webb,et al.  Freezing bulk-scale biopharmaceuticals using common techniques: and the magnitude of freeze-concentration , 2002 .

[26]  John W. Dolan,et al.  Introduction to modern liquid chromatography , 1974 .

[27]  F. Jona,et al.  Physics of Ice , 1972 .